Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Postoperative Complications 1Pancreatic Neoplasms 1

Interventions

Radiotherapy 4ferric carboxymaltose 3Ropivacaine 3Neoadjuvant Therapy 3Exercise 3Ultrasonography 2Tranexamic Acid 2Surgical Procedures, Operative 2Standard of Care 2Sodium Chloride 2Sevoflurane 2Psychiatric Rehabilitation 2Propofol 2Proctectomy 2Preoperative Exercise 2Oxaliplatin 2Lymph Node Excision 2Immunonutrition Diet 2Hepatectomy 2Fluorouracil 2Fibrin Tissue Adhesive 2Ethanol 2Dexamethasone 2Counseling 2Colectomy 2Blood Specimen Collection 2Bevacizumab 2vapreotide 1streptococcal preparation 722 1methyl N-acetylsibirosaminide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Postoperative Complications × vapreotide × Clear all
NCT00014651 2010-08-10

Vapreotide in Treating Patients Undergoing Elective Pancreatic Resection

Mayo Clinic

Phase 3 Terminated
Gastrointestinal

Pancreatic Neoplasms, Postoperative Complications

Data powered by HemOnc (CC BY 4.0) Colophon âš¡